56910-95-3 Usage
Uses
Used in Pharmaceutical Synthesis:
5-Methylbenzo[c]isothiazole is used as a key intermediate in the synthesis of pharmaceuticals for its potential biological activities. It contributes to the development of new drugs with therapeutic benefits.
Used in Agrochemical Synthesis:
In the agrochemical industry, 5-Methylbenzo[c]isothiazole is employed as a building block in the creation of agrochemicals, such as pesticides and herbicides, due to its potential to enhance the effectiveness of these products.
Used in Organic Synthesis:
5-Methylbenzo[c]isothiazole serves as a valuable building block in organic synthesis, allowing chemists to construct more complex molecules with potentially useful properties. Its unique structure makes it a versatile component in the development of novel organic compounds.
Used in Anticonvulsant Research:
5-Methylbenzo[c]isothiazole has been studied for its potential as an anticonvulsant agent, indicating its use in the development of treatments for seizure disorders and epilepsy.
Used in Antibacterial Applications:
5-Methylbenzo[c]isothiazole has also been investigated for its antibacterial properties, making it a candidate for use in the development of new antibiotics to combat bacterial infections.
Check Digit Verification of cas no
The CAS Registry Mumber 56910-95-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,9,1 and 0 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 56910-95:
(7*5)+(6*6)+(5*9)+(4*1)+(3*0)+(2*9)+(1*5)=143
143 % 10 = 3
So 56910-95-3 is a valid CAS Registry Number.
56910-95-3Relevant academic research and scientific papers
New analogs of nitrobenzylthioinosine
-
Page/Page column 28-30, (2010/11/29)
This invention relates to new analogs or derivatives of nitrobenzylthioinosine, use of these new analogs of nitrobenzylthioinosine for the treatment of pain and various other diseases as well as pharmaceuticals comprising at least on new analog of nitrobenzylthioinosine.
Inhibition of nucleoside transport by new analogues of nitrobenzylthioinosine
Deghati, Paymaneh Y. F.,Borghini, Alice,Van Den Nieuwendijk, Adrianus M. C. H.,Dissen-de Groote, Miriam,IJzerman, Adriaan P.
, p. 899 - 908 (2007/10/03)
Nitrobenzylthioinosine (NBTI, 1) was systematically modified by attachment of substituents at positions C6 and N9, and also by substitution of N1 with C. These modifications were chosen to reduce the polarity of the new compounds. Incorporation of the nitro functionality into a benzoxadiazole ring system was considered first. These new nucleosides showed high affinity (1.5-10 nM) towards the nucleoside transport protein as present on human erythrocyte ghosts. Next, modification of this benzoxadiazole ring system with C, S and O in different positions produced a number of less polar nucleosides with affinity in the higher nanomolar range. Modification of N9 was achieved with different alkyl and alcohol substituents. An n-butyl substituent proved best, although all variations yielded substantial decreases in affinity. Replacement of N1 by a carbon atom in combination with a 2-Cl substituent also resulted in a relatively potent NBTI derivative (47 nM).
